The datasets have been curated through partnerships with industry giants including Gastro Health and Allied Digestive, according to a Jan. 24 press release.
The platform will enable bio and medtech companies to develop, test and validate GI-related therapies by leveraging the insights in the datasets.
According to data from the World Health Organization, 2 billion people annually experience some form of GI diseases. Lynx.MD offers real-world data on some of the most common, including nonalcoholic fatty liver disease, gastroesophageal reflux disease, inflammatory bowel disease and colon cancer.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
